Stereoselective Synthesis of Nojirimycin α‑C‑Glycosides from a Bicyclic Acyliminium Intermediate: A Convenient Entry to N,C‑Biantennary Glycomimetics
A simple and efficient method for the stereoselective synthesis of nojirimycin α-C-glycoside derivatives has been developed using a bicyclic carbamate-type sp2-iminosugar, whose preparation on a gram scale has been optimized, as the starting material. sp2-iminosugar O-glycosides or anomeric esters s...
Saved in:
Published in | ACS omega Vol. 7; no. 26; pp. 22394 - 22405 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Chemical Society
05.07.2022
|
Online Access | Get full text |
Cover
Loading…
Abstract | A simple and efficient method for the stereoselective synthesis of nojirimycin α-C-glycoside derivatives has been developed using a bicyclic carbamate-type sp2-iminosugar, whose preparation on a gram scale has been optimized, as the starting material. sp2-iminosugar O-glycosides or anomeric esters serve as excellent precursors of acyliminium cations, which can add nucleophiles, including C-nucleophiles. The stereochemical outcome of the reaction is governed by stereoelectronic effects, affording the target α-anomer with total stereoselectivity. Thus, the judicious combination of C-allylation, carbamate hydrolysis, cross-metathesis, and hydrogenation reactions provides a very convenient entry to iminosugar α-C-glycosides, which have been transformed into N,C-biantennary derivatives by reductive amination or thiourea-forming reactions. The thiourea adducts undergo intramolecular cyclization to bicyclic iminooxazolidine iminosugar α-C-glycosides upon acid treatment, broadening the opportunities for molecular diversity. A preliminary evaluation against a panel of commercial glycosidases validates the approach for finely tuning the inhibitory profile of glycomimetics. |
---|---|
AbstractList | A simple and efficient
method for the stereoselective synthesis
of nojirimycin α-
C
-glycoside derivatives has
been developed using a bicyclic carbamate-type sp
2
-iminosugar,
whose preparation on a gram scale has been optimized, as the starting
material. sp
2
-iminosugar
O
-glycosides
or anomeric esters serve as excellent precursors of acyliminium cations,
which can add nucleophiles, including
C
-nucleophiles.
The stereochemical outcome of the reaction is governed by stereoelectronic
effects, affording the target α-anomer with total stereoselectivity.
Thus, the judicious combination of
C
-allylation,
carbamate hydrolysis, cross-metathesis, and hydrogenation reactions
provides a very convenient entry to iminosugar α-
C
-glycosides, which have been transformed into
N
,
C
-biantennary derivatives by reductive amination or thiourea-forming
reactions. The thiourea adducts undergo intramolecular cyclization
to bicyclic iminooxazolidine iminosugar α-
C
-glycosides upon acid treatment, broadening the opportunities for
molecular diversity. A preliminary evaluation against a panel of commercial
glycosidases validates the approach for finely tuning the inhibitory
profile of glycomimetics. A simple and efficient method for the stereoselective synthesis of nojirimycin α-C-glycoside derivatives has been developed using a bicyclic carbamate-type sp2-iminosugar, whose preparation on a gram scale has been optimized, as the starting material. sp2-iminosugar O-glycosides or anomeric esters serve as excellent precursors of acyliminium cations, which can add nucleophiles, including C-nucleophiles. The stereochemical outcome of the reaction is governed by stereoelectronic effects, affording the target α-anomer with total stereoselectivity. Thus, the judicious combination of C-allylation, carbamate hydrolysis, cross-metathesis, and hydrogenation reactions provides a very convenient entry to iminosugar α-C-glycosides, which have been transformed into N,C-biantennary derivatives by reductive amination or thiourea-forming reactions. The thiourea adducts undergo intramolecular cyclization to bicyclic iminooxazolidine iminosugar α-C-glycosides upon acid treatment, broadening the opportunities for molecular diversity. A preliminary evaluation against a panel of commercial glycosidases validates the approach for finely tuning the inhibitory profile of glycomimetics. A simple and efficient method for the stereoselective synthesis of nojirimycin α-C-glycoside derivatives has been developed using a bicyclic carbamate-type sp2-iminosugar, whose preparation on a gram scale has been optimized, as the starting material. sp2-iminosugar O-glycosides or anomeric esters serve as excellent precursors of acyliminium cations, which can add nucleophiles, including C-nucleophiles. The stereochemical outcome of the reaction is governed by stereoelectronic effects, affording the target α-anomer with total stereoselectivity. Thus, the judicious combination of C-allylation, carbamate hydrolysis, cross-metathesis, and hydrogenation reactions provides a very convenient entry to iminosugar α-C-glycosides, which have been transformed into N,C-biantennary derivatives by reductive amination or thiourea-forming reactions. The thiourea adducts undergo intramolecular cyclization to bicyclic iminooxazolidine iminosugar α-C-glycosides upon acid treatment, broadening the opportunities for molecular diversity. A preliminary evaluation against a panel of commercial glycosidases validates the approach for finely tuning the inhibitory profile of glycomimetics.A simple and efficient method for the stereoselective synthesis of nojirimycin α-C-glycoside derivatives has been developed using a bicyclic carbamate-type sp2-iminosugar, whose preparation on a gram scale has been optimized, as the starting material. sp2-iminosugar O-glycosides or anomeric esters serve as excellent precursors of acyliminium cations, which can add nucleophiles, including C-nucleophiles. The stereochemical outcome of the reaction is governed by stereoelectronic effects, affording the target α-anomer with total stereoselectivity. Thus, the judicious combination of C-allylation, carbamate hydrolysis, cross-metathesis, and hydrogenation reactions provides a very convenient entry to iminosugar α-C-glycosides, which have been transformed into N,C-biantennary derivatives by reductive amination or thiourea-forming reactions. The thiourea adducts undergo intramolecular cyclization to bicyclic iminooxazolidine iminosugar α-C-glycosides upon acid treatment, broadening the opportunities for molecular diversity. A preliminary evaluation against a panel of commercial glycosidases validates the approach for finely tuning the inhibitory profile of glycomimetics. A simple and efficient method for the stereoselective synthesis of nojirimycin α- -glycoside derivatives has been developed using a bicyclic carbamate-type sp -iminosugar, whose preparation on a gram scale has been optimized, as the starting material. sp -iminosugar -glycosides or anomeric esters serve as excellent precursors of acyliminium cations, which can add nucleophiles, including -nucleophiles. The stereochemical outcome of the reaction is governed by stereoelectronic effects, affording the target α-anomer with total stereoselectivity. Thus, the judicious combination of -allylation, carbamate hydrolysis, cross-metathesis, and hydrogenation reactions provides a very convenient entry to iminosugar α- -glycosides, which have been transformed into , -biantennary derivatives by reductive amination or thiourea-forming reactions. The thiourea adducts undergo intramolecular cyclization to bicyclic iminooxazolidine iminosugar α- -glycosides upon acid treatment, broadening the opportunities for molecular diversity. A preliminary evaluation against a panel of commercial glycosidases validates the approach for finely tuning the inhibitory profile of glycomimetics. |
Author | González-Cuesta, Manuel García Fernández, José Manuel García-Moreno, M. Isabel Herrera-González, Irene Ortiz Mellet, Carmen |
AuthorAffiliation | Instituto de Investigaciones Químicas (IIQ) Department of Organic Chemistry, Faculty of Chemistry |
AuthorAffiliation_xml | – name: Instituto de Investigaciones Químicas (IIQ) – name: Department of Organic Chemistry, Faculty of Chemistry |
Author_xml | – sequence: 1 givenname: Irene surname: Herrera-González fullname: Herrera-González, Irene organization: Department of Organic Chemistry, Faculty of Chemistry – sequence: 2 givenname: Manuel orcidid: 0000-0003-2778-9489 surname: González-Cuesta fullname: González-Cuesta, Manuel organization: Department of Organic Chemistry, Faculty of Chemistry – sequence: 3 givenname: M. Isabel surname: García-Moreno fullname: García-Moreno, M. Isabel organization: Department of Organic Chemistry, Faculty of Chemistry – sequence: 4 givenname: José Manuel orcidid: 0000-0002-6827-0387 surname: García Fernández fullname: García Fernández, José Manuel organization: Instituto de Investigaciones Químicas (IIQ) – sequence: 5 givenname: Carmen orcidid: 0000-0002-7676-7721 surname: Ortiz Mellet fullname: Ortiz Mellet, Carmen email: mellet@us.es organization: Department of Organic Chemistry, Faculty of Chemistry |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35811898$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kU9u1DAYxS1UREvpnhXykkWn-E_GcVggTUelVKrKorC2HOdL-40Su8TOSNn1Cuy5BBfhEJwEDzOtyoKFZct-7-dnv5dkzwcPhLzm7IQzwd9ZF0MPN_ZEOMYLVT0jB6Io2YzLQu49We-ToxhXjDGutNBCvSD7cq4515U-ID-uEwwQInTgEq6BXk8-3ULESENLr8IKB-wnh57--vn7_vsyj_NuciFiA5G2Q-ippafoJtehows3ddijx7GnFz6Te2jQJnhPF3QZ_Bo8gk_0zKdhoinQq-MN8BRt1npv8-ZfeI89JHTxFXne2i7C0W4-JF8_nn1Zfppdfj6_WC4uZ1YqmWY1aFvrirOqaVXLXV2VqmSV0nVrS2aZLedOzAVvGfCmkVxqJUqpioLpQtbzQh6SD1vu3VjnxC5nHGxn7vLTcyYTLJp_TzzempuwNpVQTFcbwNsdYAjfRojJ9BgddJ31EMZohNKaaS3ERsq2UjeEGAdoH6_hzGx6NQ-9ml2v2fLmabxHw0OLWXC8FWSrWYVx8Pm3_s_7A_8xuBE |
CitedBy_id | crossref_primary_10_1016_j_bioorg_2024_107555 crossref_primary_10_1021_acs_jmedchem_2c01948 |
Cites_doi | 10.5114/aoms.2020.94046 10.1039/C6RA23513A 10.1039/D0OB02249G 10.1039/D1OB00382H 10.1021/acs.biomac.0c01283 10.3390/v13050808 10.1002/ejoc.201900605 10.1016/B978-0-12-818349-6.00007-8 10.3390/ph12030108 10.1021/acs.orglett.9b01712 10.1016/j.jbc.2021.100470 10.1016/j.cbi.2020.109309 10.1039/b003877f 10.1039/C6CC01564F 10.1039/D1MD00217A 10.1055/s-0028-1083346 10.1038/s41551-017-0130-9 10.1016/S0040-4039(01)02218-3 10.1002/ejoc.201200923 10.1038/nrd.2017.214 10.1021/acs.chemrev.6b00806 10.1039/D1NJ01176F 10.1021/acs.joc.0c00324 10.1039/D0CC01135E 10.1016/j.carres.2016.04.006 10.1002/ejoc.200901208 10.1002/cmdc.201500407 10.1016/j.carres.2021.108317 10.1038/s41467-021-26580-6 10.1039/c3cs35525j 10.1039/c0cc00446d 10.1002/adsc.202000886 10.1002/chem.202101408 10.1016/j.tetasy.2010.01.017 10.1016/j.ejmech.2021.113716 10.1021/jacs.7b07352 10.1002/cmdc.201700558 10.1002/tcr.202100269 10.1021/jacs.1c10504 10.1055/s-0028-1083325 10.2174/0929867327666200114112728 10.1016/j.ejmech.2015.10.038 10.3390/molecules25204618 10.1002/ijch.201400150 10.1002/anie.201801202 10.3390/ph12020084 10.1093/glycob/cwaa091 10.3390/molecules24162882 10.1021/acs.joc.1c01308 10.1016/j.carres.2021.108479 10.1002/tcr.202100221 10.1016/j.ijbiomac.2017.12.148 10.1021/ol401517x 10.1038/mt.2015.62 10.1021/acs.jmedchem.0c00908 10.1002/cmdc.201700216 10.1016/j.bmcl.2004.09.086 10.1016/j.antiviral.2020.104881 10.1007/s11481-020-09925-8 10.1021/ml100192b 10.1111/imm.13393 10.1038/s42004-021-00520-3 10.1016/j.carres.2021.108491 10.1016/j.tetasy.2009.03.031 10.1039/C9SC06334J 10.1002/jcp.25832 10.1021/jo991242o 10.1039/a705755e 10.1021/cr000433k 10.1002/ejoc.201901840 10.3390/molecules23071612 10.3390/molecules24183309 10.1042/BST20160182 10.1002/jlac.199719970706 10.1002/anie.202002850 10.3390/ijms21093353 10.1039/C5OB00507H |
ContentType | Journal Article |
Copyright | 2022 The Authors. Published by American Chemical Society 2022 The Authors. Published by American Chemical Society. 2022 The Authors. Published by American Chemical Society 2022 The Authors |
Copyright_xml | – notice: 2022 The Authors. Published by American Chemical Society – notice: 2022 The Authors. Published by American Chemical Society. – notice: 2022 The Authors. Published by American Chemical Society 2022 The Authors |
DBID | N~. NPM AAYXX CITATION 7X8 5PM |
DOI | 10.1021/acsomega.2c01469 |
DatabaseName | American Chemical Society (ACS) Open Access PubMed CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | PubMed CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic PubMed |
Database_xml | – sequence: 1 dbid: N~. name: American Chemical Society (ACS) Open Access url: https://pubs.acs.org sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Chemistry |
EISSN | 2470-1343 |
EndPage | 22405 |
ExternalDocumentID | 10_1021_acsomega_2c01469 35811898 b29169181 |
Genre | Journal Article |
GrantInformation_xml | – fundername: ; grantid: FPU17/03147 – fundername: ; grantid: P20_00166 – fundername: ; grantid: NA – fundername: ; grantid: PID2019-105858RB-I00 – fundername: ; grantid: BES-2017-079676 – fundername: ; grantid: 10.13039/501100011033 – fundername: ; grantid: RTI2018-097609-B-C21 |
GroupedDBID | 53G ABFRP ABUCX ACS ADACO ADBBV AFEFF ALMA_UNASSIGNED_HOLDINGS AOIJS BCNDV EBS GROUPED_DOAJ HYE N~. OK1 RPM VF5 AAFWJ AAHBH AFPKN M~E NPM AAYXX CITATION 7X8 5PM |
ID | FETCH-LOGICAL-a363t-be8ab89109df6f1cb97670968bfa70a0a75c2521f0e1dd313862736440843b543 |
IEDL.DBID | RPM |
ISSN | 2470-1343 |
IngestDate | Tue Sep 17 21:26:41 EDT 2024 Sat Oct 26 04:10:37 EDT 2024 Fri Aug 23 03:40:23 EDT 2024 Sat Nov 02 12:13:07 EDT 2024 Thu Jul 07 05:52:05 EDT 2022 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 26 |
Language | English |
License | 2022 The Authors. Published by American Chemical Society. Permits non-commercial access and re-use, provided that author attribution and integrity are maintained; but does not permit creation of adaptations or other derivative works (https://creativecommons.org/licenses/by-nc-nd/4.0/). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-a363t-be8ab89109df6f1cb97670968bfa70a0a75c2521f0e1dd313862736440843b543 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0002-6827-0387 0000-0002-7676-7721 0000-0003-2778-9489 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260894/ |
PMID | 35811898 |
PQID | 2688088224 |
PQPubID | 23479 |
PageCount | 12 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_9260894 proquest_miscellaneous_2688088224 crossref_primary_10_1021_acsomega_2c01469 pubmed_primary_35811898 acs_journals_10_1021_acsomega_2c01469 |
PublicationCentury | 2000 |
PublicationDate | 2022-Jul-05 |
PublicationDateYYYYMMDD | 2022-07-05 |
PublicationDate_xml | – month: 07 year: 2022 text: 2022-Jul-05 day: 05 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | ACS omega |
PublicationTitleAlternate | ACS Omega |
PublicationYear | 2022 |
Publisher | American Chemical Society |
Publisher_xml | – name: American Chemical Society |
References | ref9/cit9 ref63/cit62 ref30/cit29 ref3/cit3 ref27/cit27 ref45/cit44 ref52/cit51 ref16/cit16 ref56/cit55 ref23/cit23 ref8/cit8 ref77/cit76 ref2/cit2 ref31/cit30 Sánchez-Fernández E. M. (ref58/cit57) 2020 ref59/cit58 ref70/cit69 ref37/cit36 ref74/cit73 ref71/cit70 ref20/cit20 ref34/cit33 ref48/cit47 ref17/cit17 ref40/cit39 ref10/cit10 ref53/cit52 ref35/cit34 ref19/cit19 ref21/cit21 ref29/cit28a ref46/cit45 ref42/cit41 ref67/cit66 ref13/cit13 ref49/cit48 ref75/cit74 ref61/cit60 ref24/cit24 ref64/cit63 ref38/cit37 ref6/cit6 ref72/cit71 ref18/cit18 ref50/cit49 ref43/cit42 ref11/cit11 ref25/cit25 ref36/cit35 ref32/cit31 ref39/cit38 ref76/cit75 ref14/cit14 ref51/cit50 ref5/cit5 ref57/cit56 ref65/cit64 ref28/cit28 ref54/cit53 ref68/cit67 ref26/cit26 ref73/cit72 ref55/cit54 ref69/cit68 ref60/cit59 ref12/cit12 ref15/cit15 ref66/cit65 ref62/cit61 ref22/cit22 ref33/cit32 ref47/cit46 ref41/cit40 ref4/cit4 ref1/cit1 ref7/cit7 ref44/cit43 |
References_xml | – ident: ref23/cit23 doi: 10.5114/aoms.2020.94046 – ident: ref29/cit28a doi: 10.1039/C6RA23513A – ident: ref44/cit43 doi: 10.1039/D0OB02249G – ident: ref8/cit8 doi: 10.1039/D1OB00382H – ident: ref75/cit74 doi: 10.1021/acs.biomac.0c01283 – ident: ref25/cit25 doi: 10.3390/v13050808 – ident: ref46/cit45 doi: 10.1002/ejoc.201900605 – start-page: 197 volume-title: Small Molecule Drug Discovery Methods: Molecules and Applications year: 2020 ident: ref58/cit57 doi: 10.1016/B978-0-12-818349-6.00007-8 contributor: fullname: Sánchez-Fernández E. M. – ident: ref37/cit36 doi: 10.3390/ph12030108 – ident: ref47/cit46 doi: 10.1021/acs.orglett.9b01712 – ident: ref27/cit27 doi: 10.1016/j.jbc.2021.100470 – ident: ref24/cit24 doi: 10.1016/j.cbi.2020.109309 – ident: ref72/cit71 doi: 10.1039/b003877f – ident: ref11/cit11 doi: 10.1039/C6CC01564F – ident: ref20/cit20 doi: 10.1039/D1MD00217A – ident: ref68/cit67 doi: 10.1055/s-0028-1083346 – ident: ref74/cit73 doi: 10.1038/s41551-017-0130-9 – ident: ref64/cit63 doi: 10.1016/S0040-4039(01)02218-3 – ident: ref51/cit50 doi: 10.1002/ejoc.201200923 – ident: ref13/cit13 doi: 10.1038/nrd.2017.214 – ident: ref66/cit65 doi: 10.1021/acs.chemrev.6b00806 – ident: ref34/cit33 doi: 10.1039/D1NJ01176F – ident: ref60/cit59 doi: 10.1021/acs.joc.0c00324 – ident: ref3/cit3 doi: 10.1039/D0CC01135E – ident: ref54/cit53 doi: 10.1016/j.carres.2016.04.006 – ident: ref52/cit51 doi: 10.1002/ejoc.200901208 – ident: ref39/cit38 doi: 10.1002/cmdc.201500407 – ident: ref33/cit32 doi: 10.1016/j.carres.2021.108317 – ident: ref1/cit1 doi: 10.1038/s41467-021-26580-6 – ident: ref28/cit28 doi: 10.1039/c3cs35525j – ident: ref59/cit58 doi: 10.1039/c0cc00446d – ident: ref43/cit42 doi: 10.1002/adsc.202000886 – ident: ref45/cit44 doi: 10.1002/chem.202101408 – ident: ref65/cit64 doi: 10.1016/j.tetasy.2010.01.017 – ident: ref42/cit41 doi: 10.1016/j.ejmech.2021.113716 – ident: ref5/cit5 doi: 10.1021/jacs.7b07352 – ident: ref38/cit37 doi: 10.1002/cmdc.201700558 – ident: ref14/cit14 doi: 10.1002/tcr.202100269 – ident: ref76/cit75 doi: 10.1021/jacs.1c10504 – ident: ref67/cit66 doi: 10.1055/s-0028-1083325 – ident: ref22/cit22 doi: 10.2174/0929867327666200114112728 – ident: ref69/cit68 doi: 10.1016/j.ejmech.2015.10.038 – ident: ref35/cit34 doi: 10.3390/molecules25204618 – ident: ref18/cit18 doi: 10.1002/ijch.201400150 – ident: ref4/cit4 doi: 10.1002/anie.201801202 – ident: ref17/cit17 doi: 10.3390/ph12020084 – ident: ref26/cit26 doi: 10.1093/glycob/cwaa091 – ident: ref77/cit76 doi: 10.3390/molecules24162882 – ident: ref49/cit48 doi: 10.1021/acs.joc.1c01308 – ident: ref50/cit49 doi: 10.1016/j.carres.2021.108479 – ident: ref31/cit30 doi: 10.1002/tcr.202100221 – ident: ref7/cit7 doi: 10.1016/j.ijbiomac.2017.12.148 – ident: ref71/cit70 doi: 10.1021/ol401517x – ident: ref12/cit12 doi: 10.1038/mt.2015.62 – ident: ref61/cit60 doi: 10.1021/acs.jmedchem.0c00908 – ident: ref9/cit9 doi: 10.1002/cmdc.201700216 – ident: ref73/cit72 doi: 10.1016/j.bmcl.2004.09.086 – ident: ref16/cit16 doi: 10.1016/j.antiviral.2020.104881 – ident: ref21/cit21 doi: 10.1007/s11481-020-09925-8 – ident: ref40/cit39 doi: 10.1021/ml100192b – ident: ref19/cit19 doi: 10.1111/imm.13393 – ident: ref32/cit31 doi: 10.1038/s42004-021-00520-3 – ident: ref41/cit40 doi: 10.1016/j.carres.2021.108491 – ident: ref48/cit47 doi: 10.1016/j.tetasy.2009.03.031 – ident: ref62/cit61 doi: 10.1039/C9SC06334J – ident: ref63/cit62 doi: 10.1002/jcp.25832 – ident: ref57/cit56 doi: 10.1021/jo991242o – ident: ref56/cit55 doi: 10.1039/a705755e – ident: ref6/cit6 doi: 10.1021/cr000433k – ident: ref53/cit52 doi: 10.1002/ejoc.201901840 – ident: ref30/cit29 doi: 10.3390/molecules23071612 – ident: ref36/cit35 doi: 10.3390/molecules24183309 – ident: ref15/cit15 doi: 10.1042/BST20160182 – ident: ref55/cit54 doi: 10.1002/jlac.199719970706 – ident: ref2/cit2 doi: 10.1002/anie.202002850 – ident: ref10/cit10 doi: 10.3390/ijms21093353 – ident: ref70/cit69 doi: 10.1039/C5OB00507H |
SSID | ssj0001682826 |
Score | 2.24983 |
Snippet | A simple and efficient method for the stereoselective synthesis of nojirimycin α-C-glycoside derivatives has been developed using a bicyclic carbamate-type... A simple and efficient method for the stereoselective synthesis of nojirimycin α- -glycoside derivatives has been developed using a bicyclic carbamate-type sp... A simple and efficient method for the stereoselective synthesis of nojirimycin α- C -glycoside derivatives has been developed using a bicyclic carbamate-type... |
SourceID | pubmedcentral proquest crossref pubmed acs |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 22394 |
SummonAdditionalLinks | – databaseName: American Chemical Society (ACS) Open Access dbid: N~. link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3LbtQwFLWgLGCDeDPlISPBAomUxK8k7KajlgqJ2ZRK3UWO4xSjSVLVmUU2iF9gz0_wI3wEX8K9nkzLFIRYZBXrSvFxfI99H4eQ5yaObSVrEVmpRCSs5lGu6iRSorZc2loKgxHd93N1cCTeHcvjizY5lyP4LHmtje8ae6J3mMFGJ_lVco2lcY5qBfPPOxf3KQrODkFdjYk0jhIu-BiV_JsR9EXGb_qiPwjm5TzJ3xzP_i1yc2SMdLqC-Da5Yts75PpsLdR2l3w7hLmxnQ-KNrB50cOhBVrnnaddTefdJ3fmmsG4lv74_vPL1xk8bxeD6VCo01OsL6Ga7jozmIUzdGqGBSp9uWVDw3VhqC3p7Rs6pbOQoo4VlHQPBUlo39H5KzS46xChFmt7aTDeuAbLI_09crS_92F2EI2iC5HmivdRaTNdZkAi8qoG0EwJfAWmW2VlrdNYxzqVhoHPr2ObVBVPOByJUq5QuFrwUgp-n2y1XWsfEmoqCexLppZXyHKqLC-5BUYkwEDJUzYhLwCEYvxpfBHi4Swp1mAVI1gT8nINU3G66sHxj7HP1jgWAANGP3Rru6UvmIKtKsOk2Ql5sML13Bo2gUuyPJuQdAPx8wHYhHvzTes-hmbcORwIs1xs_-e3PCI3GBZQ4AWxfEy2-rOlfQK0pi-fhvX8C-11-uA priority: 102 providerName: American Chemical Society |
Title | Stereoselective Synthesis of Nojirimycin α‑C‑Glycosides from a Bicyclic Acyliminium Intermediate: A Convenient Entry to N,C‑Biantennary Glycomimetics |
URI | http://dx.doi.org/10.1021/acsomega.2c01469 https://www.ncbi.nlm.nih.gov/pubmed/35811898 https://www.proquest.com/docview/2688088224 https://pubmed.ncbi.nlm.nih.gov/PMC9260894 |
Volume | 7 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LbtQwFLXabmCDeDMURkaCBRKeSWI7D3bTqKVC6ghpqNRd5DhOMZokVZNZZNPP4D_4Eb6Jez1J1QGJBZts4lhRzo3vuW9C3mrPM4UsBTMyFEwYxVkSlj4LRWm4NKUUGiO6Z8vw9Fx8vpAXe0SOtTAuaV_ndlavq1ltv7ncyqtKz8c8sfmXszQBEh4nYr5P9kFA75jozrESghERjCFJUGFzpdumMpdqFmhslYKNQrHrlx8nrr-qbnd10l9E8898yTsK6OQheTAwR7rYvuEjsmfqx-ReOg5se0J-rOAbmaZ1k23gEKOrvgZ619qWNiVdNt_tta16bWv66ydL2ad1rxsc1tlSrDGhih5Z3eu11XSh-zVO-7KbijqXoasv6cxHuqCpS1PHKkp6jENJaNfQ5YeUHVnEqMbqXuq2rmyFBZLtU3J-cvw1PWXD2AWmeMg7lptY5THQiKQoATadA2OJwNKJ81JFnvJUJHUAWr_0jF8U3OdgFEU8xNHVgudS8GfkoG5q84JQXUjgXzIyvECeU8RJzg1wIgEb5DwKJuQdfP5s-G3azEXEAz8bEcsGxCbk_QhQdrXtwvGPtW9GBDMAAOMfqjbNps2CEA6rGNNmJ-T5FtHb3UaBmJBoB-vbBdiGe_cOSKdrxz1I48v_fvKQ3A-wqAKdxvIVOeiuN-Y1UJ0unwLVT1dT5yiA6_JmNnXC_hst6gYc |
link.rule.ids | 230,315,730,783,787,867,888,2772,27088,27092,27936,27937,53804,53806,57066,57090,57116,57140 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3NbtQwELZKOZRL-afLr5HggESWJLbzw20btSzQ7oFtpd6ixHHAsElQnT2EE6_AnZfgRXgInoQZb3bLFoTgkEtijZzx2PON54-QR9J1VSFK7igRcIerjDlxUHpOwEvFhCoFl-jRPZwE42P-6kScbBBvmQsDkzBAyVgn_ll1Ae8ZvGsq9TYb-hLrncQXyEURgr5ENJRMz65VAjAhbJM1n4eu4zHOeufkn4igSpJmXSX9hjPPh0v-on_2L5M3q5nbsJMPw3mbD-Wnc0Ud_-vXrpDtHo3S0UJ8rpINVV8jW8myCdx18nUKfFeNsd1y4GCk064GyGi0oU1JJ817faqrTuqafv_24_OXBJ4Xs0422ATUUMxdoRnd1bKTMy3pSHYz7CKm5xW1V5E2b6VVz-mIJjb8HbMz6R42O6FtQydPkeCuxtWvMW-YWuKVrjD10twgx_t7R8nY6Rs6OBkLWOvkKsryCABKXJQgEDIHLBSCDRXlZRa6mZuFQvqAJ0pXeUXBPAbmVsgCbIrNWS44u0k266ZWO4TKQgCyE6FiBSKoIopzpgBtcSCQs9AfkMfA1rTfkCa1vnbfS5e8TnteD8iT5dqnHxf1Pf4y9uFSOFJYBvSsZLVq5ib1AzgGIwzIHZBbC2FZUcMCc14URwMSronRagAW-F7_Uut3ttB3DMZmFPPb__gvD8jW-OjwID14OXl9h1zyMVEDL6LFXbLZns7VPYBPbX7fbpifPzAcew |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3NbtQwELZKkaCXiv8u5cdIcEAiJYnt_HDbLl3K3wqpVOotShy7NdokVZ095IJ4Be68BC_CQ_AkzHiTwgJCHHJJrFGSL8584_HMR8hD6fuqFJp7SkTc4ypnXhrpwIu4VkwoLbjEjO7bWbR_yF8diaM1IoZaGLgJC5asS-LjrD4tdd9hIHgK55tKHec7ocSeJ-kFclFgwznUu_y483NpJYIwwgmthTz2vYBx1ico_2YE3ZK0q27pD675-5bJX3zQ9ArZ7MkjHS_RvkrWVH2NXJ4Mmm3XyZcDeE2qsU7cBv5j9KCrgeFZY2mj6az5YM5M1UlT029fv3_6PIHjxbyTDWp2WoqlJjSnu0Z2cm4kHctujqJfZlFRt3Loykxa9YyO6cTtVsdiSrqH2iS0bejsCRrcNQhWjWW-1BmvTIWVkvYGOZzuvZ_se73-gpeziLVeoZK8SIBPpKUG_GQB1CWGkCcpdB77uZ_HQobg_rWvgrJkAYPoKGYRalhzVgjObpL1uqnVFqGyFEDERKxYiYSnTNKCKSBHHAwULA5H5BGAkPXzx2YuNR4G2QBW1oM1Io8HmLLTZTuOf4x9MOCYAQyYCMlr1SxsFkbw10pw_-yI3Friem4N-8EFSZqMSLyC-PkA7Me9eqU2J64vdwqxYZLy2__5LPfJpXfPp9mbl7PX22QjxLIKXDYWd8h6e7ZQd4HstMU992n_ADu2AaU |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Stereoselective+Synthesis+of+Nojirimycin+%CE%B1%E2%80%91C%E2%80%91Glycosides+from+a+Bicyclic+Acyliminium+Intermediate%3A+A+Convenient+Entry+to+N%2CC%E2%80%91Biantennary+Glycomimetics&rft.jtitle=ACS+omega&rft.au=Herrera-Gonza%CC%81lez%2C+Irene&rft.au=Gonza%CC%81lez-Cuesta%2C+Manuel&rft.au=Garci%CC%81a-Moreno%2C+M.+Isabel&rft.au=Garci%CC%81a+Ferna%CC%81ndez%2C+Jose%CC%81+Manuel&rft.date=2022-07-05&rft.pub=American+Chemical+Society&rft.issn=2470-1343&rft.eissn=2470-1343&rft.volume=7&rft.issue=26&rft.spage=22394&rft.epage=22405&rft_id=info:doi/10.1021%2Facsomega.2c01469&rft.externalDocID=b29169181 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2470-1343&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2470-1343&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2470-1343&client=summon |